BMO Capital analyst Jim Birchenough came out today with a research report on Regeneron Pharmaceutals Inc (NASDAQ:REGN), reiterating a Market Perform rating on the stock with a …
Biotech has been in a funk for over a week now, though Friday finished strong. iShares’ NASDAQ Biotechnology ETF (IBB) has been stuck …
It’s been an eventful week on the pipeline front with companies like Biogen Inc (NASDAQ:BIIB), Prothena Corporation PLC (NASDAQ:PRTA) and Vertex Pharmaceuticals Incorporated …
One of the more anticipated events of early 2015 played out on Friday – detailed results from an early study of Biogen Idec Inc's (NASDAQ:BIIB) experimental …
In a research report issued Friday, Chardan Capital analyst Gbola Amusa initiated coverage on shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) with a Buy rating and a price target …
Just a day after Retrophin Inc. (NASDAQ:RTRX) announced a $100 million financing the U.
